VivoSim Labs, INC. — Director's Dealing 2016

Jul 14, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ORGANOVO HOLDINGS, INC. (ONVO)
CIK: 0001497253
Period of Report: 2016-07-11

Reporting Person: David Eric (CSO & EVP Pre-Clinical Dev)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-07-11	Common Stock	A	50000	$0.00	Acquired	726306	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-07-11	Stock Option (Right to Buy)	$3.99	A	100000	Acquired	2026-07-11	Common Stock (100000)	Direct

Footnotes

F1: Annual long-term equity award approved by the Compensation Committee of the Issuer's Board of Directors.

F2: The shares represent a grant of Restricted Stock Units ("RSUs"). The RSUs represent a right to receive shares of the Issuer's common stock, at no additional conversion or exercise price. The RSUs vest and settle over 16 equal quarterly installments measured from May 15, 2016.

F3: This number does not include 1,070,000 shares of common stock underlying outstanding options held by Dr. David; post-transaction Dr. David beneficially owns or has a right to acquire 1,796,306 shares of common stock.

F4: The option shares vest and become exercisable over 16 equal quarterly installments measured from May 15, 2016.